Aadi Bioscience, Inc. (AADI) Tops Q3 EPS by 9c

Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q3 EPS of ($0.68), $0.09 better than the analyst estimate of ($0.77). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $3.11 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Occidental Petroleum releases Q2 2026 earnings considerations
• What Delta’s report tells investors in American and United